Background-The prevalence of hepatitis C virus (HCV) infection has been estimated at 43 to 84% in patients with essential mixed cryoglobulinaemia in recent large series. Some of these cases have been successfully treated with interferona. The objective was to evaluate the prevalence and the possible role of HCV infection in essential mixed cryoglobulinaemia. Methods-Fifteen patients (eight men and seven women; mean age: 612 (SD 16.5) years) with peripheral neuropathy (10 polyneuropathies and five multifocal mononeuropathies) and essential mixed cryoglobulinaemia were tested for serum anti-HCV antibodies. Results-Antibodies were found in 10 of 15 patients involving either polyneuropathies (seven patients) or multifocal mononeuropathies (three patients). Electrophysiological studies and teased nerve fibre studies (in seven patients) allowed neuropathies to be classified as predominantly sensory axonopathies. Compared with HCV-negative (HCV -) patients, HCV-positive (HCV +) patients had a more pronounced and more widespread motor deficit; motor nerve conduction velocities in peroneal and median nerves were more impaired in HCV + patients, although significance was not reached except for the mean value of the amplitude of the compound muscle action potentials of the median nerves (P < 0-05); necrotising vasculitis was found in two of nine nerve biopsies from the HCV + patients studied and in none of the three HCV -patients. In addition, HCV + patients had more frequent cryoglobulin related cutaneous signs, higher aminotransferase and serum cryoglobulin concentrations, lower total haemolytic complement concentrations, and more frequent presence of rheumatoid factor. A liver biopsy performed in eight HCV + patients disclosed a range of lesions, from chronic active hepatitis (six patients) to persistent hepatitis (two patients). Lastly, treatment with interferon-a conducted over six months in two patients seemed to improve the peripheral neuropathy. Conclusions-Patients with peripheral neuropathy and essential mixed cryoglobulinaemia should be tested for anti-HCV antibodies to determine the appropriate treatment.
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The aim of this study was to evaluate the prevalence and possible role of HCV antibodies in a group of patients with peripheral neuropathy and essential mixed cryoglobulinaemia.
Patients and methods

PATIENTS
Fifteen patients (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) were retrospectively selected in the neurology and internal medicine departments of our university hospital on the basis of (1) a peripheral neuropathy based on clinical and electrophysiological findings and (2) essential mixed cryoglobulinaemia diagnosed as described later. We included only the patients with positive mixed cryoglobulinaemia (corresponding to types II and III) on two successive determinations, with a serum concentration higher than 0 05 g/l. We excluded patients having an underlying disease known to be associated with mixed cryoglobulinaemia: autoimmune disorders, nonviral infectious diseases, and malignant haematological disorders. Also, other causes of peripheral neuropathy were systematically excluded. Electrophysiological data In the electrophysiological study, MNCVs were more often abnormal in HCV + patients than in HCV -patients. The MNCVs in peroneal nerves could not be elicited in five of 10 HCV + patients compared with one of five HCV -patients; in the remaining patients, the mean value of MNCV was lower (38-2 (SD 2 3) m/s) and the mean value of distal motor latencies was higher (SD 2-3) ms) in HCV + patients than in HCV -patients (respectively 45 (SD 1 7) m/s and 5 05 (SD) 0 5 ms), although significance was not reached. In median nerves, the mean value of MNCV was lower in HCV + patients than in HCV -patients (49-3 (SD 2-3) v 53-5 (SD 2-7) m/s, but not significantly), and the mean value of the amplitude of the CMAP was significantly lower in HCV + patients than in HCV -patients (4 9 (SD 0 4) v 8-1 (SD 0 8) mV, P < 0 05). In addition, fibrillation potentials, indicating active denervation, were seen in three HCV + patients, compared with only one HCV -patient.
Pathological data on neuromuscular biopsies Necrotising vasculitis was found in two of nine of the HCV + patients studied (muscle only: one patient, nerve only: one patient), but not in any of the three HCV -patients studied. In addition, perivascular infiltrates of mononuclear cells without involvement of the vascular wall, indicating an inflammatory process, were seen in five of nine HCV + patients (both nerve and muscle: three patients, nerve only: two patients), but were not present in any of the three HCV -patients. In the nerve, the infiltrates were seen both in the endoneurium and in the epineurium.
On the other hand, there was no significant difference in the mean density of myelinated fibres between the two groups: 3174 (SD 2460) in the seven HCV + patients studied, compared with 3310 (SD 2278) in the three HCV -patients studied (normal control value used in our laboratory: 9300 (SD 2300)).
Other features associated with cryoglobulinaemia Other cryoglobulin related signs were more frequent in HCV + patients than in HCVpatients (nine of 10 and one of five, respectively), mainly for cutaneous signs (five of 10 and none of five, respectively). In addition, the mean cryoglobulin serum concentration was significantly higher in HCV + patients than in HCV -patients: 0-62 (SD 0 43) g/l v 0-08 (SD 0 04 g/l) (P < 0 05). Compared with HCV -patients, the HCV + patients had a lower mean total haemolytic complement (27 5 (SD 7) CH5,/ml v 40-1 (SD 5 7) CH5,,iml), and a rheumatoid factor more often positive (eight of 10 v one of five).
Liver: serological and pathological data Abnormalities in liver function tests were found in all HCV + patients: alanine aminotransferase concentrations were 1 2 to seven times above the upper normal limits, whereas they were normal at repeated examinations in HCV -patients. Among the HCV + cases, seven had a risk factor for HCV transmission: blood transfusion (n = 2), intravenous drug addiction (n = 1), and surgery (n = 4), whereas none of the HCV -patients had risk factors for HCV infection. The eight HCV + patients who underwent a liver biopsy had a range of liver histological lesions ranging from chronic active hepatitis (n = 6) to persistent hepatitis (n = 2). No correlation could be found between the severity of liver pathological lesions and the severity of the peripheral neuropathy or the neuromuscular vasculitis lesions.
Response to treatment Four of the five HCV -patients have been treated with a series of 10 to 15 plasma exchanges, resulting in slight to mild improvement of the sensory symptoms. Four of the 10 HCV + patients were treated with steroids and/or cyclophosphamide, associated in three patients with plasma exchanges, for six to 18 months: two patients had a mild response and one had a good response to this treatment. The other six patients received interferon-a (three million units three times a week) because of the presence of active hepatitis: four of them could not be evaluated because the duration of treatment was too short (< four months) or due to drop out. In the remaining two patients interferon treatment, conducted over six months to one year, led to a dramatic improvement in the peripheral neuropathy coupled with the disappearance of cryoglobulinaemia.
Discussion
Peripheral neuropathy may be associated with all types of cryoglobulinaemias. However, the more often described association is that of essential mixed cryoglobulinaemia, and either polyneuropathies or multifocal mononeuropathies: a personal review of 45 documented cases reported in the medical literature shows that this association is found in 84% of patients.14-2' The clinical and electrophysiological profile of the peripheral neuropathies in our patients did not differ from that previously reported: polyneuropathies were more frequent than multifocal mononeuropathies, as in the study of Gemignani et alP; paresthesiae and pain were classic symptoms.2' 26 Electrophysiological findings and sural nerve biopsy specimens were consistent with predominant axonal degeneration in most cases. Vascular lesions, including vasculitis and alterations of the endoneurial microvessels, were commonly seen in the peripheral nerves, as in previously documented cases. '8-20 However, the different histopathological aspects may reflect various stages of the disease, rather than the different forms of a pathological process.2829
On the other hand, the high prevalence of (1) anti-HCV antibodies in the serum, and (2) HCV RNA in the serum and/or cryoprecipitates, in patients with essential mixed cryoglobulinaemia, suggests a direct role of HCV in the production of cryoglobulinaemia. The prevalence of anti-HCV antibodies in our selected group, using second generation HCV tests, was higher than that (52%) found in a series of unselected patients with essential mixed cryoglobulinaemia,'0 but lower than that reported by Authier et a126 in a recent study of 10 patients similar to ours. However, systematically screening for HCV RNA by PCR may raise the proportion of detected patients.'0 27 We wished to know whether the presence of anti-HCV antibodies may allow the characteristic features in peripheral neuropathy associated with essential mixed cryoglobulinaemia to be determined. When HCV + patients were compared with HCV -patients, the peripheral neuropathy in HCV + patients seemed to be more severe, mainly because of motor involvement. These clinical findings were confirmed in our study by some of the results of the electrophysiological studies. In addition, direct or indirect signs of vasculitis were more frequent and more severe in the HCV + patients studied. More precisely, necrotising vasculitis was seen in two of our 10 HCV + patients, and could be related to a direct role of HCV infection, in the absence of associated HBV active infection. On the other hand the patient recently reported by Khella et al30 of peripheral neuropathy associated with mixed cryoglobulinaemia and hepatitis C infection, had a primarily axonal neuropathy with a vasculitic destruction of the epineurial vessels, but fibrinoid necrosis was not found: these authors suggest that the absence of hepatitis C virus particles from their patient's nerve supports the hypothesis of indirect damage to the nerve, perhaps by the cryoglobulins or the inflammatory cells.
Considering the non-neurological manifestations, Cacoub et al'0 showed that patients with HCV have more frequent cryoglobulin related cutaneous involvement, higher alanine aminotransferase concentrations, higher serum cryoglobulin concentrations, lower CH50, and more frequent presence of rheumatoid factor, than patients without HCV. Moreover, liver histological lesions are very often found in HCV + patients. A role for HCV in the development of mixed cryoglobulinaemia has recently been suggested: a possible explanation for their association could be an antigenic cross reaction between HCV and the liver, particularly if damaged, with the production of antibodies cross reacting with both antigens. IO Consequently, the presence of chronic active hepatitis in liver biopsies led us to propose a treatment with interferon-a, which seemed to be efficacious in hepatic lesions and could also improve the peripheral neuropathy. Khella et alP0 treated their patient with interferon a for nine months, which improved the symptoms and cleared the hepatitis C viral RNA and cryoglobulin from the serum.
In conclusion, a high proportion of patients with peripheral neuropathy associated with essential mixed cryoglobulinaemia are suspected of having serum anti-HCV antibodies, and these patients seem to have a more severe neurological condition. Patients with peripheral neuropathy and essential mixed cryoglobulinaemia have to be evaluated for anti-HCV antibodies so that the degree of hepatic impairment can be evaluated and a suitable treatment proposed. Prospective studies are needed to determine whether interferon-a may also be considered as a treatment for peripheral neuropathy.
